Clinical value of procalcitonin for suspected nosocomial bloodstream infection
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Procalcitonin (PCT) may prove to be a useful marker to exclude or predict bloodstream infection (BSI). However, the ability of PCT levels to differentiate BSI from non-BSI episodes has not been evaluated in nosocomial BSI. Methods: We retrospectively reviewed the medical records of patients ≥ 18 years of age with suspected BSI that developed more than 48 hours after admission. Results: Of the 785 included patients, 105 (13.4%) had BSI episodes and 680 (86.6%) had non-BSI episodes. The median serum PCT level was elevated in patients with BSI as compared with those without BSI (0.65 ng/mL vs. 0.22 ng/mL, p = 0.001). The optimal PCT cut-off value of BSI was 0.27 ng/mL, with a corresponding sensitivity of 74.6% (95% confidence interval [CI], 66.4% to 81.7%) and a specificity of 56.5% (95% CI, 52.7% to 60.2%). The area under curve of PCT (0.692) was significantly larger than that of C-reactive protein (CRP; 0.526) or white blood cell (WBC) count (0.518). However, at the optimal cut-off value, PCT failed to predict BSI in 28 of 105 cases (26.7%). The PCT level was significantly higher in patients with an eGFR < 60 mL/min/1.73 m2 than in those with an eGFR ≥ 60 mL/min/1.73 m2 (0.68 vs. 0.17, p = 0.01). Conclusions: PCT was more useful for predicting nosocomial BSI than CRP or WBC count. However, the diagnostic accuracy of predicting BSI remains inadequate. Thus, PCT is not recommended as a single diagnostic tool to avoid taking blood cultures in the nosocomial setting.
Abstract
Background/Aims: Procalcitonin (PCT) may prove to be a useful marker to exclude or predict bloodstream infection (BSI). However, the ability of PCT levels to differentiate BSI from non-BSI episodes has not been evaluated in nosocomial BSI. Methods: We retrospectively reviewed the medical records of patients ≥ 18 years of age with suspected BSI that developed more than 48 hours after admission. Results: Of the 785 included patients, 105 (13.4%) had BSI episodes and 680 (86.6%) had non-BSI episodes. The median serum PCT level was elevated in patients with BSI as compared with those without BSI (0.65 ng/mL vs. 0.22 ng/mL, p = 0.001). The optimal PCT cut-off value of BSI was 0.27 ng/mL, with a corresponding sensitivity of 74.6% (95% confidence interval [CI], 66.4% to 81.7%) and a specificity of 56.5% (95% CI, 52.7% to 60.2%). The area under curve of PCT (0.692) was significantly larger than that of C-reactive protein (CRP; 0.526) or white blood cell (WBC) count (0.518). However, at the optimal cut-off value, PCT failed to predict BSI in 28 of 105 cases (26.7%). The PCT level was significantly higher in patients with an eGFR < 60 mL/min/1.73 m2 than in those with an eGFR ≥ 60 mL/min/1.73 m2 (0.68 vs. 0.17, p = 0.01). Conclusions: PCT was more useful for predicting nosocomial BSI than CRP or WBC count. However, the diagnostic accuracy of predicting BSI remains inadequate. Thus, PCT is not recommended as a single diagnostic tool to avoid taking blood cultures in the nosocomial setting.
참고문헌 (44)
- Pittet D, "Nosocomial bloodstream infections: secular trends in rates, mortality, and contribution to total hospital deaths", Arch Intern Med, 155, pp.1177~1184 (1995)[DOI]
- Parrillo JE, "Pathogenetic mechanisms of septic shock", N Engl J Med, 328, pp.1471~1477 (1993)[DOI]
- Nakamura A, "Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit", Shock, 31, pp.586~591 (2009)
- Hoenigl M, "Characteristics of hospital-acquired and community-onset blood stream infections, South-East Austria", PLoS One, 9, pp.e104702~ (2014)[DOI]
- Diekema DJ, "Epidemiology and outcome of nosocomial and community-onset bloodstream infection", J Clin Microbiol, 41, pp.3655~3660 (2003)[DOI]
- Kollef MH, "Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study", J Infect, 62, pp.130~135 (2011)[DOI]
- Leibovici L, "The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection", J Intern Med, 244, pp.379~386 (1998)[DOI]
- Goncalves-Pereira J, "Bloodstream infections as a marker of community-acquired sepsis severity: results from the Portuguese community-acquired sepsis study (SACiUCI study)", Clin Microbiol Infect, 19, pp.242~248 (2013)[DOI]
- Jensen JU, "Procalcitonin increase in early identification of critically ill patients at high risk of mortality", Crit Care Med, 34, pp.2596~2602 (2006)[DOI]
- Mitaka C, "Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome", Clin Chim Acta, 351, pp.17~29 (2005)[DOI]
- Bates DW, "Predicting bacteremia in patients with sepsis syndrome: Academic Medical Center Consortium Sepsis Project Working Group", J Infect Dis, 176, pp.1538~1551 (1997)[DOI]
- Jaimes F, "Predicting bacteremia at the bedside", Clin Infect Dis, 38, pp.357~362 (2004)[DOI]
- Clyne B, "The C-reactive protein", J Emerg Med, 17, pp.1019~1025 (1999)[DOI]
- Assicot M, "High serum procalcitonin concentrations in patients with sepsis and infection", Lancet, 341, pp.515~518 (1993)[DOI]
- Riedel S, "Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department", Am J Clin Pathol, 135, pp.182~189 (2011)[DOI]
- Hattori T, "Clinical value of procalcitonin for patients with suspected bloodstream infection", Am J Clin Pathol, 141, pp.43~51 (2014)[DOI]
- Levy MM, "2001 SCCM", ESICM, ATS, pp.SIS International Sepsis Definitions Conference, Crit Care Med[DOI]
- Stevens LA, "Assessing kidney function: measured and estimated glomerular filtration rate", N Engl J Med, 354, pp.2473~2483 (2006)[DOI]
- Liaudat S, "Usefulness of procalcitonin serum level for the diagnosis of bacteremia", Eur J Clin Microbiol Infect Dis, 20, pp.524~527 (2001)[DOI]
- Chirouze C, "Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever", Clin Infect Dis, 35, pp.156~161 (2002)[DOI]
- Hoenigl M, "Procalcitonin fails to predict bacteremia in SIRS patients: a cohort study", Int J Clin Pract, 68, pp.1278~1281 (2014)[DOI]
- Groeneveld AB, "The role of the innate immune response in hospital- versus community-acquired infection in febrile medical patients", Int J Infect Dis, 12, pp.660~670 (2008)[DOI]
- Laupland KB, "Community-onset bloodstream infection during the 'after hours' is not associated with an increased risk for death", Can J Infect Dis Med Microbiol, 23, pp.170~172 (2012)
- Hoeboer SH, "The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis", Clin Microbiol Infect, 21, pp.474~481 (2015)[DOI]
- Oussalah A, "Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (a STROBE-compliant article)", Medicine (Baltimore), 94, pp.e1774~ (2015)[DOI]
- Brechot N, "Procalcitonin to guide antibiotic therapy in the ICU", Int J Antimicrob Agents, 46(Suppl 1), pp.S19~S24 (2015)[DOI]
- Meisner M, "Clinical experiences with a new semiquantitative solid phase immunoassay for rapid measurement of procalcitonin", Clin Chem Lab Med, 38, pp.989~995 (2000)
- Wagner KE, "Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs", Crit Care Med, 30, pp.2313~2321 (2002)[DOI]
- Mimoz O, "Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome", Intensive Care Med, 24, pp.185~188 (1998)[DOI]
- Carsin H, "Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury", Burns, 23, pp.218~224 (1997)[DOI]
- Kylanpaa-Back ML, "Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis", Crit Care Med, 29, pp.63~69 (2001)[DOI]
- Meisner M, "Postoperative plasma concentrations of procalcitonin after different types of surgery", Intensive Care Med, 24, pp.680~684 (1998)[DOI]
- Charles PE, "Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria", BMC Infect Dis, 8, pp.38~ (2008)[DOI]
- Kumar S, "Recognition of bacterial infection by innate immune sensors", Crit Rev Microbiol, 39, pp.229~246 (2013)[DOI]
- Echchannaoui H, "Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation", J Infect Dis, 186, pp.798~806 (2002)[DOI]
- Takeuchi O, "Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components", Immunity, 11, pp.443~451 (1999)[DOI]
- Poltorak A, "Defective LPS signaling in C3H", HeJ and C57BL, Science, pp.1998, 282[DOI]
- Meisner M, "The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function", Eur J Anaesthesiol, 18, pp.79~87 (2001)
- Amour J, "Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery", Crit Care Med, 36, pp.1147~1154 (2008)[DOI]
- Dahaba AA, "Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis", Intensive Care Med, 29, pp.579~583 (2003)[DOI]
- Park JH, "Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study", Crit Care, 18, pp.640~ (2014)[DOI]
- Herget-Rosenthal S, "Modulation and source of procalcitonin in reduced renal function and renal replacement therapy", Scand J Immunol, 61, pp.180~186 (2005)[DOI]
- Sitter T, "Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin", J Nephrol, 15, pp.297~301 (2002)
- Marra AR, "Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection", J Clin Microbiol, 44, pp.1342~1346 (2006)[DOI]